NCT05364294 Molecular Diagnosis of Systemic Autoinflammatory Diseases
| NCT ID | NCT05364294 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Inflammatory Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-05-18 |
| Primary Completion | 2032-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-05-18 with a primary completion date of 2032-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.
Eligibility Criteria
Inclusion Criteria: * A patient presenting with a clinical and biological aseptic inflammatory syndrome associating one or more of the following signs: spontaneously resolving fever, abdominal (pain, diarrhea), locomotor (arthralgia, myalgia), thoracic (pain, pericarditis), cutaneous, sensory (uveitis, deafness), or renal (amyloidosis) involvement. Exclusion Criteria: * Adult subject to legal protection measures (guardianship, curatorship, safeguard of justice).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05364294 clinical trial?
This trial is open to participants of all sexes, aged 1 Week or older, up to 120 Years, studying Inflammatory Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05364294 currently recruiting?
Yes, NCT05364294 is actively recruiting participants. Contact the research team at irina.giurgea@inserm.fr for enrollment information.
Where is the NCT05364294 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05364294 clinical trial?
NCT05364294 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 300 participants.